Clinical Trial Update: Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating intra-tumoral Mitazalimab (CD40 antibody) in combination with irreversible electroporation for locally advanced pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Mitazalimab (mitazalimab)

Snippet

Sponsor: University of California, San Diego | Conditions: Pancreatic Cancer | Phase 1 | Status: RECRUITING